Literature DB >> 3871945

Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

J L Cole, G A Housley, T R Dykman, R P MacDermott, J P Atkinson.   

Abstract

Proteins binding the third component of complement (C3) were isolated by affinity chromatography from surface-labeled solubilized membranes of human peripheral blood cells and cell lines. The isolated molecules were subjected to NaDodSO4/PAGE, and autoradiographs of these gels indicated that C3-binding proteins could be divided into three groups based on Mr: (i) gp200, an approximately 200,000 Mr molecule previously identified as the C3b/C4b receptor or CR1; (ii) gp140, an approximately 140,000 Mr molecule previously identified as the C3d receptor or CR2; and (iii) gp45-70, a heretofore unrecognized group of 45,000-70,000 Mr C3-binding molecules. The cell distribution, Mr, antigenic cross-reactivity, and specificity of gp45-70 were examined. Erythrocytes have no detectable gp45-70, but all leukocyte populations examined possess this group of molecules. On neutrophils and mononuclear phagocytes, CR1 is the predominant C3-binding glycoprotein, but gp45-70 is present on both cell populations and on macrophage and neutrophil cell lines. B plus null cells, chronic lymphocytic leukemia cells, and an Epstein-Barr virus-transformed B-cell line possess CR1, CR2, and gp45-70. On T cells and T-cell lines gp45-70 is the predominant or, in some cases, the only C3-binding protein isolated. gp45-70 is structurally characterized as a broad band or doublet with a mean Mr that is slightly different for each cell population. gp45-70 binds iC3, C3b, and C4b, but not C3d, indicating that the binding region is probably within the C3c portion of C3b. A polyclonal antibody to CR1 and monoclonal antibodies to CR1 and CR2 do not immunoprecipitate gp45-70. While gp45-70 has not been previously characterized on human cells, a C3b-binding glycoprotein of similar Mr is present on rabbit alveolar macrophages. We conclude that gp45-70 is an additional group of membrane proteins present on human leukocytes that possess ligand-binding activity for C3b.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871945      PMCID: PMC397146          DOI: 10.1073/pnas.82.3.859

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Characterization of a human B cell-specific antigen (B2) distinct from B1.

Authors:  L M Nadler; P Stashenko; R Hardy; A van Agthoven; C Terhorst; S F Schlossman
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

3.  Further characterization of the human autologous mixed leukocyte reaction (MLR).

Authors:  R P MacDermott; M C Stacey
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.

Authors:  N J Dobson; J D Lambris; G D Ross
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  Isolation of a biologically active macrophage receptor for the third component of complement.

Authors:  R J Schneider; A Kulczycki; S K Law; J P Atkinson
Journal:  Nature       Date:  1981-04-30       Impact factor: 49.962

6.  Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.

Authors:  K Hong; T Kinoshita; K Inoue
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.

Authors:  K Hong; T Kinoshita; H Kitajima; K Inoue
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

8.  Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.

Authors:  Y Miyakawa; A Yamada; K Kosaka; F Tsuda; E Kosugi; M Mayumi
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

9.  Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

Authors:  D T Fearon
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

10.  Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.

Authors:  K Iida; R Mornaghi; V Nussenzweig
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  57 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Membrane-associated complement factor H on lymphoblastoid cell lines Raji expresses a co-factor activity for the factor I-mediated cleavage of C3b.

Authors:  M J Demares
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

Review 3.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement.

Authors:  M Matsumoto; T Seya; S Nagasawa
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

Review 5.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

6.  Regulation of complement membrane attack complex formation in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

8.  Tissue distribution of the guinea-pig decay-accelerating factor.

Authors:  K Nishikawa; S Matsuo; H Tamai; N Okada; H Okada
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein.

Authors:  K J Micklem; R B Sim
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

10.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.